KKR To Acquire Indian Medical Device Maker Healthium From Apax
(Bloomberg) -- KKR & Co. is acquiring Bengaluru-based medical device maker Healthium Medtech Ltd. from private equity firm Apax Partners, in another example of India's growing allure to global investors.
KKR intends to use a special purpose vehicle to buy a controlling stake, it said in a joint statement with Healthium and Apax on Monday. The announcement confirmed a Bloomberg News report from April, when people familiar with the matter said a transaction could be valued at as much as $1 billion.
The investment will be made through KKR's Asian Fund IV, according to Monday's statement, which didn't disclose financial details. The deal is expected to be completed in the third quarter this year.
“Healthium has established itself as a leading homegrown producer of medical devices with a strong track record of delivering quality products and a wide distribution network both in India and globally,” KKR partner and head of India private equity, Akshay Tanna, said in the statement. KKR will accelerate Healthium's growth organically and through mergers and acquisitions, he said.
Apax acquired Healthium in 2018. The medical device company says it has a presence in more than 90 countries and its products are used in one-in-five surgeries globally.
KKR's other health-care investments in India and the Asia-Pacific region include JB, Max Healthcare, Gland Pharma, PHC Holdings, Bushu Pharmaceuticals and Metro Pacific Hospitals. Bloomberg reported in March that KKR was considering possibly selling its stake in Metro Pacific.
More stories like this are available on bloomberg.com
©2024 Bloomberg L.P.
-
We May Need Another Tukaram Mundhe To Fight Air Pollution | The Reason Why
Developers may install basic measures such as sprinklers and green nets, resume work, and continue violating rules when this equipment stops working.
-
Extracting Value From Battery Scrap Could Be Challenging For India | The Reason Why
A discarded lithium-ion battery still contains valuable materials such as lithium, nickel and cobalt. These can be recovered and reused. When such batteries are crushed and shredded, they produce a dark powder called black mass.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.